Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

QuantumPharm Inc

2228
Current price
4.31 HKD -0.53 HKD (-10.95%)
Last closed 4.95 HKD
ISIN KYG1992K1067
Sector Healthcare
Industry Health Information Services
Exchange Hong Kong Stock Exchange
Capitalization 16 592 198 932 HKD
Yield for 12 month -25.69 %
1Y
3Y
5Y
10Y
15Y
2228
21.11.2021 - 28.11.2021

XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company's drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research. The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024. XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China. Address: Second Phase of the International, Shenzhen, China

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

80.62 HKD

P/E ratio

Dividend Yield

Current Year

+1 320 523 990 HKD

Last Year

+1 406 417 006 HKD

Current Quarter

+296 579 939 HKD

Last Quarter

+367 244 897 HKD

Current Year

Last Year

Current Quarter

+82 173 333 HKD

Last Quarter

+127 503 921 HKD

Key Figures 2228

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -718 556 655 HKD
Operating Margin TTM -413.26 %
PE Ratio
Return On Assets TTM
PEG Ratio
Return On Equity TTM
Wall Street Target Price 80.62 HKD
Revenue TTM 197 400 481 HKD
Book Value 5.65 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 28.30 %
Dividend Yield
Gross Profit TTM
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2015
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 2228

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History 2228

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3:1
Payout Ratio
Last Split Date 11.08.2015
Dividend Date

Stock Valuation 2228

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 65.09
Price Sales TTM 84.05
Enterprise Value EBITDA
Price Book MRQ 3.90

Financials 2228

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2228

For 52 weeks

3.05 HKD 16.23 HKD
50 Day MA 5.71 HKD
Shares Short Prior Month
200 Day MA 7.27 HKD
Short Ratio
Shares Short
Short Percent